Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, PMD Device Solutions AB's enterprise value is kr43.96 Mil.
PMD Device Solutions AB's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was kr-18.49 Mil. Therefore, PMD Device Solutions AB's EV-to-EBITDA for today is -2.38.
The historical rank and industry rank for PMD Device Solutions AB's EV-to-EBITDA or its related term are showing as below:
OSTO:PMDS's EV-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 14.59 * Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
PMD Device Solutions AB (OSTO:PMDS) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
PMD Device Solutions AB's PE Ratio (TTM) for today is calculated as:
PMD Device Solutions AB's share price for today is kr0.66.
PMD Device Solutions AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.400.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:PMDS vs ABT, SYK, BSX: EV-to-EBITDA Comparison
For the Medical Devices subindustry, PMD Device Solutions AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PMD Device Solutions AB EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PMD Device Solutions AB's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where PMD Device Solutions AB's EV-to-EBITDA falls into.
PMD Device Solutions AB's current Enterprise Value is kr43.96 Mil.
PMD Device Solutions AB's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-18.49 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PMD Device Solutions AB (OSTO:PMDS) has a EV-to-EBITDA of -2.38 as of Aug. 28, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on PMD Device Solutions AB.
Is PMD Device Solutions AB's EV-to-EBITDA too high?
PMD Device Solutions AB's current EV-to-EBITDA is -2.38. Overall, PMD Device Solutions AB has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does PMD Device Solutions AB's EV-to-EBITDA compare to ABT and SYK?
PMD Device Solutions AB's EV-to-EBITDA of -2.38 can be compared against companies in the Medical Devices & Instruments industry. The industry median EV-to-EBITDA is 14.59. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.59, based on 523 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on PMD Device Solutions AB. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PMD Device Solutions AB's current EV-to-EBITDA is -2.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PMD Device Solutions AB stock overvalued right now?
PMD Device Solutions AB (OSTO:PMDS) has a current EV-to-EBITDA of -2.38. The current EV-to-EBITDA is -2.38. PMD Device Solutions AB's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For PMD Device Solutions AB (OSTO:PMDS), the current EV-to-EBITDA is -2.38 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PMD Device Solutions AB develops and sells medical products for respiratory monitoring in both the hospital and homecare setting. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to detect deterioration of a patient's general condition early and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is, to the Company's knowledge, the world's only continuous, motion-tolerant respiratory rate monitor delivering class-leading reliability in measuring respiratory rate. RespiraSense is a novel technology that is commercialised in Europe, the UK, and FDA-cleared in the US.
4GF Score
Get the complete analysis for OSTO:PMDS
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:PMDS has been successfully added to your 
